These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34244054)

  • 1. The estimated burden of 15 vaccine-preventable diseases from 2008 to 2020 in Japan: A transition by the COVID-19 pandemic.
    Kitano T
    J Infect Chemother; 2021 Oct; 27(10):1482-1488. PubMed ID: 34244054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of COVID-19 restrictions and border closures on vaccine preventable diseases in Victoria, Australia, 2020-2021.
    Bhatt P; Strachan J; Easton M; Franklin L; Drewett G
    Commun Dis Intell (2018); 2022 May; 46():. PubMed ID: 35591751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of social distancing on incidence of vaccine-preventable diseases, South Korea.
    Yun HE; Ryu BY; Choe YJ
    J Med Virol; 2021 Mar; 93(3):1814-1816. PubMed ID: 33079384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A model for the incremental burden of invasive Haemophilus influenzae type b due to a decline of childhood vaccination during the COVID-19 outbreak: A dynamic transmission model in Japan.
    Kitano T; Aoki H
    Vaccine; 2021 Jan; 39(2):343-349. PubMed ID: 33280853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short term impact of the COVID-19 pandemic on incidence of vaccine preventable diseases and participation in routine infant vaccinations in the Netherlands in the period March-September 2020.
    Middeldorp M; van Lier A; van der Maas N; Veldhuijzen I; Freudenburg W; van Sorge NM; Sanders EAM; Knol MJ; de Melker HE
    Vaccine; 2021 Feb; 39(7):1039-1043. PubMed ID: 33478793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of non-pharmaceutical interventions on the incidences of vaccine-preventable diseases during the COVID-19 pandemic in the eastern of China.
    Sun X; Xu Y; Zhu Y; Tang F
    Hum Vaccin Immunother; 2021 Nov; 17(11):4083-4089. PubMed ID: 34374635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006.
    Menzies R; Turnour C; Chiu C; McIntyre P
    Commun Dis Intell Q Rep; 2008 Jun; 32 Suppl():S2-67. PubMed ID: 18711998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Immune Recovery-Based Revaccination Protocol for Pediatric Hematopoietic Stem Cell Transplant Recipients: Revaccination Outcomes Following Pediatric HSCT.
    Haynes AS; Curtis DJ; Campbell K; Giller RH; Quinones RR; Verneris MR; Abzug MJ
    Transplant Cell Ther; 2021 Apr; 27(4):317-326. PubMed ID: 33836875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of vaccine-preventable diseases in Japan: considerations for pre-travel advice for the 2019 Rugby World Cup and 2020 Summer Olympic and Paralympic Games.
    Griffith MM; Fukusumi M; Kobayashi Y; Matsui Y; Nishiki S; Shimbashi R; Morino S; Sunagawa T; Tanaka-Taya K; Matsui T; Oishi K
    Western Pac Surveill Response J; 2018; 9(2):26-33. PubMed ID: 30057855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine hesitancy among people with multiple sclerosis.
    Yap SM; Al Hinai M; Gaughan M; Callanan I; Kearney H; Tubridy N; McGuigan C
    Mult Scler Relat Disord; 2021 Nov; 56():103236. PubMed ID: 34507240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease Burden of 32 Infectious Diseases in the Netherlands, 2007-2011.
    van Lier A; McDonald SA; Bouwknegt M; ; Kretzschmar ME; Havelaar AH; Mangen MJ; Wallinga J; de Melker HE
    PLoS One; 2016; 11(4):e0153106. PubMed ID: 27097024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The burden of selected vaccine-preventable diseases on the secondary care health system in England: Results from a five-year administrative healthcare dataset.
    Rabe APJ; Costello P; Were JJ; Farrer A; Hudson RDA
    Vaccine; 2022 Nov; 40(48):6939-6946. PubMed ID: 36280563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine co-administered with a booster dose of a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in healthy children aged 12-23 months.
    Zepp F; Behre U; Kindler K; Laakmann KH; Pankow-Culot H; Mannhardt-Laakmann W; Beckers F; Descamps D; Willems P
    Eur J Pediatr; 2007 Aug; 166(8):857-64. PubMed ID: 17541639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine preventable diseases and vaccination coverage in Australia, 1993-1998.
    McIntyre P; Amin J; Gidding H; Hull B; Torvaldsen S; Tucker A; Turnbull F; Burgess M
    Commun Dis Intell; 2000 Jun; Suppl():v-83. PubMed ID: 12049363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and immunogenicity of a measles, mumps, rubella and varicella vaccine given with combined Haemophilus influenzae type b conjugate/hepatitis B vaccines and combined diphtheria-tetanus-acellular pertussis vaccines.
    Shinefield H; Black S; Thear M; Coury D; Reisinger K; Rothstein E; Xu J; Hartzel J; Evans B; Digilio L; Schödel F; Brown ML; Kuter B;
    Pediatr Infect Dis J; 2006 Apr; 25(4):287-92. PubMed ID: 16567978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2006-2010.
    Naidu L; Chiu C; Habig A; Lowbridge C; Jayasinghe S; Wang H; McIntyre P; Menzies R
    Commun Dis Intell Q Rep; 2013 Dec; 37 Suppl():S1-95. PubMed ID: 24410428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low immunity against vaccine preventable diseases in Turkish HIV cohort.
    Candevir A; Kuşcu F; Yıldırım F; Kömür S; Şentürk GÇ; İnal AS; Eser F; Çetiner S; Kurtaran B; Taşova Y
    Turk J Med Sci; 2021 Oct; 51(5):2311-2317. PubMed ID: 33984893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pneumococcal and Influenza Vaccination Rates and Pneumococcal Invasive Disease Rates Set Geographical and Ethnic Population Susceptibility to Serious COVID-19 Cases and Deaths.
    Root-Bernstein R
    Vaccines (Basel); 2021 May; 9(5):. PubMed ID: 34066697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global and regional burden of vaccine-associated facial paralysis, 1967-2023: Findings from the WHO international pharmacovigilance database.
    Jeong YD; Lee K; Lee S; Park J; Kim HJ; Lee J; Kang J; Jacob L; Smith L; Rahmati M; López Sánchez GF; Dragioti E; Son Y; Kim S; Yeo SG; Lee H; Yon DK
    J Med Virol; 2024 Jun; 96(6):e29682. PubMed ID: 38783823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timeliness and completeness of routine childhood vaccinations in young children residing in a district with recurrent vaccine-preventable disease outbreaks, Jerusalem, Israel.
    Stein-Zamir C; Israeli A
    Euro Surveill; 2019 Feb; 24(6):. PubMed ID: 30755293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.